Corticosteroid Injections and COVID-19 Infection Risk | Zendy

D. Craig Miller | Zendy; Jaymin Patel | Zendy; Jatinder Gill | Zendy; Ryan Mattie | Zendy; Mathew Saffarian | Zendy; Byron J. Schneider | Zendy; Adrian Popescu | Zendy; Vivek Babaria | Zendy; Zachary L. McCormick | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Corticosteroid Injections and COVID-19 Infection Risk

Author(s) -

D. Craig Miller,

Jaymin Patel,

Jatinder Gill,

Ryan Mattie,

Mathew Saffarian,

Byron J. Schneider,

Adrian Popescu,

Vivek Babaria,

Zachary L. McCormick

Publication year - 2020

Publication title -

pain medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.893

H-Index - 97

eISSN - 1526-4637

pISSN - 1526-2375

DOI - 10.1093/pm/pnaa199

Subject(s) - covid-19 , medicine , corticosteroid , pandemic , betacoronavirus , intensive care medicine , virology , outbreak , disease , infectious disease (medical specialty)

*Napa Pain Institute, Napa, California; Department of Orthopaedics, Emory University, Atlanta, Georgia; Department of Anesthesiology, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Interventional Pain & Spine, Providence CedarsSinai Tarzana Medical Center, Los Angeles, California; Department of Physical Medicine and Rehabilitation, Michigan State University, East Lansing, Michigan; kDepartment of Physical Medicine and Rehabilitation, Vanderbilt University, Nashville, Tennessee; kkDepartment of Physical Medicine and Rehabilitation, Hospital of University of Pennsylvania, Philadelphia, Pennsylvania; **Orange County Spine and Sports, PC, Interventional Physiatry, Costa Mesa, California; Division of Physical Medicine and Rehabilitation, University of Utah, Salt Lake City, Utah, USA

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research